Clinical Trial: Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07296276) titled 'Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM' on Dec. 11.

Brief Summary: This is a prospective, single arm, open-label, interventional, pilot study to evaluate the accuracy and precision of the continuous glucose monitoring (CGM) system of i-SENS, Inc., CareSens Air 3, in adult patients with type 1 diabetes.

Study Start Date: Dec. 29

Study Type: INTERVENTIONAL

Condition: Type 1 Diabetes Mellitus

Intervention: DEVICE: CareSens Air 3 primary insertion

Primary CareSens Air 3 device

DEVICE: CareSens Air 3 secondary insertion

Secondary CareSens Air 3 device

Recr...